Patents by Inventor Sabine Riffault

Sabine Riffault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8252289
    Abstract: The invention relates to N protein-protein of interest fusion proteins, optionally in the form of soluble N protein-protein of interest/P protein complexes, the N and P proteins being proteins of a virus of the Paramyxoviridae family. When the protein of interest is an antigen, the invention relates also to vaccinal compositions and diagnostic reagents comprising those N protein-antigen fusion proteins or those N protein-antigen/P protein complexes. The N protein-protein of interest fusion protein can also be used as a “vector” for transporting into cells therapeutic molecules of interest, such as antivirals or anticancer agents.
    Type: Grant
    Filed: April 18, 2007
    Date of Patent: August 28, 2012
    Assignee: Institut National de la Recherche Agronomique (INRA)
    Inventors: Jean-François Eleouët, Sabine Riffault
  • Patent number: 8071334
    Abstract: The invention relates to a method for preparation of soluble N-protein/truncated P-protein complex of a virus of the family Paramyxoviridae, complexes prepared thus and the soluble N-proteins which may be isolated from said complexes. The invention further relates to vaccine compositions comprising said N-protein/truncated P-protein complexes or N-proteins from Paramyxoviridae.
    Type: Grant
    Filed: April 27, 2006
    Date of Patent: December 6, 2011
    Assignee: Institut National de la Recherche Agronomique
    Inventors: Jean-Francois Eleouet, Sabine Riffault
  • Publication number: 20100021490
    Abstract: The invention relates to a method for preparation of soluble N-protein/truncated P-protein complex of a virus of the family Paramyxoviridae, complexes prepared thus and the soluble N-proteins which may be isolated from said complexes. The invention further relates to vaccine compositions comprising said N-protein/truncated P-protein complexes or N-proteins from Paramyxoviridae.
    Type: Application
    Filed: April 27, 2006
    Publication date: January 28, 2010
    Applicant: Institut National De La Recherche Agronomique (INRA)
    Inventors: Jean-Francois Eleouet, Sabine Riffault
  • Publication number: 20090186337
    Abstract: The invention relates to N protein-protein of interest fusion proteins, optionally in the form of soluble N protein-protein of interest/P protein complexes, the N and P proteins being proteins of a virus of the Paramyxoviridae family. When the protein of interest is an antigen, the invention relates also to vaccinal compositions and diagnostic reagents comprising those N protein-antigen fusion proteins or those N protein-antigen/P protein complexes. The N protein-protein of interest fusion protein can also be used as a “vector” for transporting into cells therapeutic molecules of interest, such as antivirals or anticancer agents.
    Type: Application
    Filed: April 18, 2007
    Publication date: July 23, 2009
    Inventors: Jean-Francois Eleouet, Sabine Riffault